adivo

Planegg, Germany Founded: 2018 • Age: 8 yrs Acquired By Zoetis
Species-specific antibodies for pets are developed via a specialized platform.
Annual revenue - Latest available
Total funding - 3 rounds
Employees - Tracked headcount
Investors 5 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About adivo

adivo is a company based in Planegg (Germany) founded in 2018 by Markus Waldhuber and Kathrin Ladetzki was acquired by Zoetis in September 2023. adivo offers products and services including Medicines and Vaccines and Diagnostics.

  • Headquarter Planegg, Germany
  • Founders Markus Waldhuber, Kathrin Ladetzki
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Zoetis Services Llc
Operational Areas
Not available
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $2.45 M (USD), Grant

    Oct 17, 2022

  • Investors
    Zoetis

    & 4 more

  • Employee Count
    Not available
  • Acquired by
    Zoetis

    (Sep 15, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of adivo

adivo offers a comprehensive portfolio of products and services, including Medicines and Vaccines and Diagnostics.

Product name locked
Category locked
Primary

These are developed to predict, prevent, detect, and treat diseases in animals, supporting healthier lives for pets and livestock.

Product name locked
Category locked
Locked

Tools are provided for detecting animal illnesses, which aids in effective health management across various species.

People of adivo

Headcount 5000-10000
Employee Profiles 1026
Board Members and Advisors 13
Employee Profiles
People
Megan Castro
Corporate And Strategic Senior Account Manager
People
John Drinkell
Director - Business Operations Effectiveness
People
Catherine Maguire
Technical Services Veterinarian
People
Leen van Brussel
Veterinary Clinical Manager

Unlock access to complete

Board Members and Advisors
people
Sanjay Khosla
Director
people
Louise M. Parent
Director
people
Willie M. Reed
Director
people
Gregory Norden
Director

Unlock access to complete

Funding Insights of adivo

Investors in adivo

adivo has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Zoetis, MorphoSys and EIC Fund.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Locked Locked Locked
Venture capital investments are provided to deep-tech startups.
Locked Locked Locked
Early-stage investments are made in high-tech startups by HTGF.
Locked Locked Locked
Premium access

Investor details for adivo

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by adivo

Investments
Premium access

Investment portfolio details for adivo

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - adivo

Premium access

Detailed financials for adivo

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Adivo Comparisons

adivo Primary company
Description
Species-specific antibodies for pets are developed via a spe...
Location
Planegg, Germany
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for adivo

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of adivo

Premium access

Detailed competitors of adivo

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Adivo

Premium access

Complete news archive for adivo

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about adivo

adivo was founded in 2018.

adivo is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.

Adivo was founded in 2018 in Planegg, Germany, within the veterinary biotechnology sector. Technology platforms are developed by the company to create species-specific antibodies tailored for pets. These antibodies are selected from a library of options to ensure optimal fit for animal health applications. Operations focus on advancing antibody development processes for the pet care industry, with co-founders Markus Waldhuber and Kathrin Ladetzki leading efforts.

adivo offers Medicines and Vaccines and Diagnostics.

adivo has 5 investors. Key investors include Zoetis, MorphoSys, EIC Fund, OCCIDENT, and High-Tech Gründerfonds.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available